Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 625 E. KALISTE SALOOM RD. LAFAYETTE LA 70508 |
Tel: | 1-905-3261888 |
Website: | https://www.viemed.com |
IR: | See website |
Key People | ||
Michael Moore President | Casey Hoyt Chief Executive Officer, Director | Trae Paul Fitzgerald Chief Financial Officer |
W. Todd Zehnder Chief Operating Officer, Director | Jerome Richard II Cambre Vice President - Sales | Patrick Eagan General Counsel, Company Secretary | William Frazier Chief Medical Officer, Director |
Business Overview |
Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company's service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company's products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed). |
Financial Overview |
For the fiscal year ended 31 December 2023, Viemed Healthcare Inc revenues increased 32% to $183M. Net income increased 65% to $10.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from $0.16 to $0.27. |
Employees: | 996 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $302.08M as of Dec 31, 2023 |
Annual revenue (TTM): | $183.01M as of Dec 31, 2023 |
EBITDA (TTM): | $36.87M as of Dec 31, 2023 |
Net annual income (TTM): | $10.24M as of Dec 31, 2023 |
Free cash flow (TTM): | $19.12M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 38,756,636 as of Feb 9, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |